$190.00Original price was: $190.00.$132.00Current price is: $132.00.
This unique formulation combines four clinically significant compounds with complementary mechanisms to support metabolic optimization, cellular recovery, and systemic energy regulation
This unique formulation combines four clinically significant compounds with complementary mechanisms to support metabolic optimization, cellular recovery, and systemic energy regulation.
Semaglutide, a GLP-1 receptor agonist, is clinically utilized to enhance satiety, improve insulin sensitivity, and promote sustained weight loss.
BPC-157, a pentadecapeptide derived from gastric proteins, is associated with accelerated wound healing, GI repair, tendon and ligament regeneration, and anti-inflammatory modulation.
L-Carnitine, a naturally occurring amino acid derivative, plays a critical role in mitochondrial fatty acid transport, promoting energy production and metabolic flexibility.
Methylcobalamin (Vitamin B12) supports methylation cycles, red blood cell synthesis, nerve function, and energy conversion at the cellular level.
This combination is designed to synergistically target core systems including metabolic regulation, mitochondrial function, vascular healing, and neuroprotection.
Semaglutide acts as an analog of human GLP-1 (glucagon-like peptide-1), binding to GLP-1 receptors in the pancreas and brain. It enhances glucose-dependent insulin secretion, inhibits glucagon release, and delays gastric emptying, ultimately reducing appetite and caloric intake. It also activates hypothalamic satiety centers [1][2].
BPC-157 activates angiogenic growth factors, particularly VEGF and FAK-paxillin pathways, supporting capillary regeneration, anti-inflammatory cytokine modulation, and tissue-specific repair. It upregulates eNOS and influences dopaminergic and serotonergic systems [3][4].
L-Carnitine facilitates the transport of long-chain fatty acids into the mitochondrial matrix, essential for beta-oxidation and ATP synthesis. It may also reduce oxidative stress markers and improve insulin sensitivity in skeletal muscle [5].
Methylcobalamin serves as a cofactor for methionine synthase, supporting DNA methylation, myelin sheath maintenance, and homocysteine clearance. It also plays a role in energy metabolism via succinyl-CoA production [6][7].
There are limited data on the use of Semaglutide or BPC-157 in pregnancy. Animal studies suggest Semaglutide may cause embryofetal toxicity at high doses [9]. BPC-157’s effects on reproductive tissues have not been fully elucidated. Use of this formulation is not recommended during pregnancy or lactation unless under specific clinical justification.
Safety and efficacy of this multi-agent formulation in pediatric populations have not been established. Due to the complexity of hormonal, metabolic, and neurological development in children, this product is not advised for use in individuals under 18 years of age unless under specialized medical supervision.
Semaglutide is FDA-approved under the trade names Ozempic®, Wegovy®, and Rybelsus® for type 2 diabetes and chronic weight management.
BPC-157 is not currently FDA-approved but has been extensively studied in preclinical models for regenerative purposes.
L-Carnitine (Rx version Carnitor®) and Methylcobalamin are FDA-approved as individual compounds for deficiencies and metabolic support.
⚠️This specific formulation is not an FDA-approved combination product and should be used in accordance with professional guidance and applicable regulations.
